RxDoctor Payments DataLook up a doctor →

Philipp Wiesner, MD

Interventional Cardiology · Springfield, MONPI 1609162817

Payments from drug & device makers

$151,661in general payments, 2019–2025

Across 867 payments — averaging $174.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$72K
  • Eko Health, Inc.$18K
  • Janssen Research & Development, LLC$15K
  • Edwards Lifesciences$10K
  • Boston Scientific$7K
  • Medtronic$5K
  • plus $24K from 42 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis13$71,963
Eko Health, Inc.2$18,020
Janssen Research & Development, LLC1$15,200
Edwards Lifesciences130$9,877
Boston Scientific154$7,265
Medtronic(2 entities)65$5,446
Philips North America LLC79$5,120
Abbott70$4,507
Abiomed39$3,020
Amgen52$1,383
Cardiovascular Systems Inc.16$1,370
Biotronik Inc.11$989
Asahi Intecc USA, Inc.9$712
Terumo Medical Corporation8$662
Teleflex LLC6$628
Angiodynamics, Inc.3$625
Boehringer Ingelheim35$588
E.r. Squibb & Sons, L.L.C.26$466
Pfizer22$407
Penumbra, Inc.8$398
Shockwave Medical, Inc6$380
AstraZeneca23$365
Kestra Medical Technology Services, Inc.5$227
Heartflow, Inc.7$208
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)16$199
Inspire Medical Systems, Inc.1$178
Sanofi-aventis U.S. LLC4$173
Amarin Pharma, Inc.12$171
Recor Medical Inc1$147
Johnson & Johnson11$136
Cvrx, Inc.1$127
Biosense Webster, Inc.1$111
Daiichi Sankyo Inc.6$103
Chiesi USA, Inc.2$67
Novo Nordisk4$59
Inari Medical, Inc.1$57
Bayer3$51
W. L. Gore & Associates, Inc.3$47
Siemens Medical Solutions USA, Inc.1$45
Corcym Inc1$33
Esperion Therapeutics, Inc.2$29
Livanova USA, Inc.1$20
Bard Peripheral Vascular, Inc.1$17
Nipro Medical Corporation1$16
Amryt Pharma Holdings Ltd1$15
Vifor Pharma, Inc.1$14
Kowa Pharmaceuticals America, Inc.1$12
Kls-martin L.p.1$11

How this compares

$151,661 in reported general payments places this provider in the 80th percentile of 182 interventional cardiology providers in Missouri.

See all interventional cardiology providers in Missouri →

Medicare billing

Part B allowed, 2024
$370,505
Medicare patients
1,658
Services billed
3,644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Springfield

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →